925442-01-9

Upstream product

• 67-56-1 methanol 
• 925442-00-8 2,3,6-Trimethyl-4-[(trifluoromethyl)sulfonyl]benzaldehyde 
• 201230-82-2 carbon monoxide 
• 41827-90-1 4-hydroxy-2,3,6-trimethylbenzaldehyde 

Downstream Products

• 925442-08-6 Methyl 4-(1,3-dioxan-2-yl)-2,3,5-trimethylbenzoate 
• 925442-15-5 4-[(2,4-dichlorophenoxy)methyl]-2,3,6-trimethylbenzaldehyde 
• 925442-09-7 [4-(1,3-Dioxan-2-yl)-2,3,5-trimethylphenyl]methanol 
• 925442-11-1 4-[(2-butynyloxy)methyl]2,3,6-trimethylbenzaldehyde 
• 925442-10-0 4-(Hydroxymethyl)-2,3,6-trimethylbenzaldehyde 

Relevant academic research and scientific papers

NOVEL CERCOSPORAMIDE DERIVATIVE

The present invention relates to a novel cercosporamide derivative, a pharmacologically acceptable salt thereof or an ester thereof which has an excellent hypoglycemic effect and is useful as a therapeutic and/or prophylactic agent for diabetes. A cercosporamide derivative having the general formula (I): [wherein X represents an oxygen atom or the like, R1 represents a hydrogen atom or a C1-C6 alkyl group, R2 represents a hydrogen atom, a C1-C6 alkyl group or a C1-C6 halogenated alkyl group, R3 represents a hydrogen atom or a C1-C6 alkyl group, R4 represents a C6-C10 aryl group which may be substituted with one to five group(s) independently selected from Substituent Group a, or the like, n represents 1, 2 or 3, and Substituent Group a represents a halogen atom, a C1-C6 alkyl group, a C1-C6 halogenated alkyl group, a C2-C6 alkenyl group, a C2-C6 alkynyl group, a C1-C6 alkoxy group, a C1-C6 halogenated alkoxy group, a C2-C6 alkenyloxy group, a C2-C6 alkynyloxy group and the like], a pharmacologically acceptable salt thereof or an ester thereof.